Update on the medical treatment of metastatic renal cell carcinoma.


CONTEXT Metastatic renal cell carcinoma (mRCC) has long been treated only by immunotherapy with good results only in a small population of patients. In recent years, major improvements in treatment possibilities have occurred with the advent of anti-angiogenic drugs. In the past 2 yr, pivotal phase III trials have confirmed this major breakthrough by… (More)
DOI: 10.1016/j.eururo.2008.04.056

3 Figures and Tables


  • Presentations referencing similar topics